International Journal of Cancer

Article	Citations
Cancer statistics for the year 2020: An overview	2548
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies	296
A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale	220
Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050	158
Liquid biopsies: Potential and challenges	142
Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities	110
Novel insights into the function of CD24: A driving force in cancer	108
Cancer associates with risk and severe events of COVID‐19: A systematic review and meta‐analysis	97
Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer	92
The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction	91
The role of CDK6 in cancer	91
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020	91
Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors	88
Caspase‐8: A key protein of cross‐talk signal way in “PANoptosis” in cancer	84
Is it possible to halve the incidence of liver cancer in China by 2050?	84
Profiling global cancer incidence and mortality by socioeconomic development	80
The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha‐fetoprotein	78
Incidence of childhood renal tumours: An international population‐based study	78
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies	75
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization	74
Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039	67
Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada	65
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC‐ESCC2019): A multicenter, phase 2 study	65
Thyroid cancer, recent advances in diagnosis and therapy	59
Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study	58

The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance	57
Cancer in Iran 2008 to 2025: Recent incidence trends and short‐term predictions of the future burden	56
Dysbiosis of the endometrial microbiota and its association with inflammatory cytokines in endometrial cancer	55
Drugging “undruggable” genes for cancer treatment: Are we making progress?	53
The role of SIRT2 in cancer: A novel therapeutic target	53
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE‐042 China St	52
muTarget: A platform linking gene expression changes and mutation status in solid tumors	52
The potential of breast cancer screening in Europe	52
Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced es	51
GSDME and its role in cancer: From behind the scenes to the front of the stage	51
Vulvar intraepithelial neoplasia: Incidence and long‐term risk of vulvar squamous cell carcinoma	50
The European response to the WHO call to eliminate cervical cancer as a public health problem	50
Cervical cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index: A population‐based registry study	49
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II	48
Histone lysine demethylases and their functions in cancer	46
Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study	45
Global patterns in testicular cancer incidence and mortality in 2020	45
Cost of decentralized CAR T‐cell production in an academic nonprofit setting	45
A demonstration of automated visual evaluation of cervical images taken with a smartphone camera	45
S100 calcium‐binding protein A9 from tumor‐associated macrophage enhances cancer stem cell‐like properties of hepatocellular carcinoma	45
Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients	43
Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer	43
Circulating insulin‐like growth factor‐I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank	42
Exploring the interactions between Helicobacter pylori (Hp) infection and other risk factors of gastric cancer: A pooled analysis in the Stomach cancer Pooling (StoP) Project	42
Cellular heterogeneity landscape in laryngeal squamous cell carcinoma	41
Tumor‐associated macrophage‐targeted therapeutics in ovarian cancer	40
Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral‐host interaction with implications for disease intervention	40
Hepatitis B virus infection and the risk of cancer among the Chinese population	40
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma	40
Feasibility of deep learning‐based fully automated classification of microsatellite instability in tissue slides of colorectal cancer	40
Composite dietary antioxidant index and the risk of colorectal cancer: Findings from the Singapore Chinese Health Study	39
Prospective analyses of testosterone and sex hormone‐binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank	39
Long‐term exposure to air pollution and liver cancer incidence in six European cohorts	38
Epigenetic regulation of cancer stem cell formation and maintenance	38
Loss of the cystine/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice	38
A systematic review and meta‐analysis of cytology and HPV‐related biomarkers for anal cancer screening among different risk groups	38
Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers	37
Endometrial cancer in Lynch syndrome	37
Diagnosis of digestive system tumours	36
Clinical impact of probiotics on the efficacy of anti‐PD‐1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probabili	36
Neuronal signatures in cancer	35
Circulating tumor HPV DNA complements PET‐CT in guiding management after radiotherapy in HPV‐related squamous cell carcinoma of the head and neck	35
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma	35
Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials	35
Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges	35
Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors	34
International trends in incidence of osteosarcoma (1988‐2012)	34
Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study	34
Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study	34
Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank	34

Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients	33
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)	33
Identifying predictors of HPV‐related head and neck squamous cell carcinoma progression and survival through patient‐derived models	33
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer	33
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma	33
The effects of TNF‐α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer	33
Meta‐analysis of agreement/concordance statistics in studies comparing self‐ vs clinician‐collected samples for HPV testing in cervical cancer screening	33
Outdoor light at night and postmenopausal breast cancer risk in the NIH‐AARP diet and health study	33
Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors	33
Geographic and temporal variations in the incidence of vulvar and vaginal cancers	32
The International Collaboration for Cancer Classification and Research	32
Genetically driven CD39 expression shapes human tumor‐infiltrating CD8+ T‐cell functions	32
Withdrawn: circLgr4 drives colorectal tumorigenesis and invasion through Lgr4‐targeting peptide	32
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017	31
Metabolic syndrome and risk of pancreatic cancer: A population‐based prospective cohort study	31
Late effects, long‐term problems and unmet needs of cancer survivors	30
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II	30
The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing	30
Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients	29
Sleep duration and risk of overall and 22 site‐specific cancers: A Mendelian randomization study	29
Selection of high‐risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China	29
Camrelizumab plus oxaliplatin‐based chemotherapy as first‐line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial	29
Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the European Prospective Investigation into Cancer and Nu	29
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases	29
Global burden of HPV‐attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis	28
Cancer incidence and cancer death in relation to tobacco smoking in a population‐based Australian cohort study	28
Characterization of hepatitis B virus infection and viral DNA integration in non‐Hodgkin lymphoma	28
Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL‐HBV and HCV studies	28
Low prevalence of IgG antibodies to SARS‐CoV‐2 in cancer patients with COVID‐19	28
Relationship between tRNA‐derived fragments and human cancers	28
Time trends of neoadjuvant chemotherapy for early breast cancer	28
Circulating adipokine concentrations and risk of five obesity‐related cancers: A Mendelian randomization study	28
Site‐specific metastasis: A cooperation between cancer cells and the metastatic microenvironment	28
Fruits and vegetables intake and gastric cancer risk: A pooled analysis within the Stomach cancer Pooling Project	27
Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV‐positive head and neck cancer	27
The genomic profile of parathyroid carcinoma based on whole‐genome sequencing	27
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma	27
The roles of PAD2‐ and PAD4‐mediated protein citrullination catalysis in cancers	27
Cancer risk and mortality after solid organ transplantation: A population‐based 30‐year cohort study in Finland	27
Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland	27
Do certified cancer centers provide more cost‐effective care? A health economic analysis of colon cancer care in Germany using administrative data	27
Radiomics predicts response of individual HER2‐amplified colorectal cancer liver metastases in patients treated with HER2‐targeted therapy	27
Global and national trends in the age‐specific sex ratio of esophageal cancer and gastric cancer by subtype	27
Real‐world outcomes of advanced melanoma patients not represented in phase III trials	26
Novel imaging techniques for intraoperative margin assessment in surgical oncology: A systematic review	26
The impact of the COVID‐19 pandemic on the short‐term survival of patients with cancer in Northern Portugal	26
Research on esophageal cancer: With personal perspectives from studies in China and Kenya	26
Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: A Mendelian randomization study	26
HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1	26
Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93‐01, 2001 and UK‐IMPORT database: A	26
Value of upper gastrointestinal endoscopy for gastric cancer surveillance in patients with Lynch syndrome	26
Oral and gastric microbiome in relation to gastric intestinal metaplasia	26
Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study	26
Dietary inflammatory potential, oxidative balance score, and risk of breast cancer: Findings from the Sister Study	26
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data	25
Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study	25
UBC12‐mediated SREBP‐1 neddylation worsens metastatic tumor prognosis	25
Alcohol consumption, DNA methylation and colorectal cancer risk: Results from pooled cohort studies and Mendelian randomization analysis	25
Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics	25
Alterations in the oral and gut microbiome of colorectal cancer patients and association with host clinical factors	25
Esophageal cancer in China: Practice and research in the new era	25
Association between inflammatory bowel disease and prostate cancer: A large‐scale, prospective, population‐based study	25
Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer	25
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin‐based chemotherapy in metastatic castration‐resistant prostate cancer	25
Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040	25
Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial	25
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab	24
Alcohol metabolism genes and risks of site‐specific cancers in Chinese adults: An 11‐year prospective study	24
Chronic restraint stress promotes the mobilization and recruitment of myeloid‐derived suppressor cells through β‐adrenergic‐activated CXCL5‐CXCR2‐Erk signaling cascades	24
Classification of high‐grade cervical intraepithelial neoplasia by p16ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates consi	24
Dietary fatty acids and colorectal cancer risk in men: A report from the Shanghai Men's Health Study and a meta‐analysis	24
Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort	24
Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV‐related oropharyngeal cancer and cancer of unknown primary	24
A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial	24
Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis	24
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?	23
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first‐line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1)	23
Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial	23
miR‐34a is upregulated in AIP‐mutated somatotropinomas and promotes octreotide resistance	23
Risk‐stratified strategies in population screening for colorectal cancer	23

African‐specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer	23
Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes	23
Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A	22
Targeting CTLA‐4 in cancer: Is it the ideal companion for PD‐1 blockade immunotherapy combinations?	22
Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls	22
Genome‐wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility	22
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant nonsmall cell lung cancer with brain metastasis	22
Progress, challenges and ways forward supporting cancer surveillance in Latin America	22
Effective methylation triage of HPV positive women with abnormal cytology in a middle‐income country	22
Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer	22
Targeting type I collagen for cancer treatment	22
Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases	22
Lung mechanics modifications facilitating metastasis are mediated in part by breast cancer‐derived extracellular vesicles	22
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis	22
Circulating tryptophan metabolites and risk of colon cancer: Results from case‐control and prospective cohort studies	21
Exploring the impact of gut microbiota and diet on breast cancer risk and progression	21
Public health insurance and cancer‐specific mortality risk among patients with breast cancer: A prospective cohort study in China	21
Selenium and cancer risk: Wide‐angled Mendelian randomization analysis	21
Age disparities in stage‐specific colon cancer survival across seven countries: An International Cancer Benchmarking PartnershipSURVMARK‐2 population‐based study	21
Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population‐based multistate cohort study including 4 618 377 adults in Catalonia, Spain	21
The aryl hydrocarbon receptor promotes inflammation‐induced dedifferentiation and systemic metastatic spread of melanoma cells	21
Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank	21
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division	21
Global patterns of non‐Hodgkin lymphoma in 2020	21
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha‐1 chain (PRO‐C11) in patients with pancreatic ductal adenocarcinoma	21
Opium use and the risk of head and neck squamous cell carcinoma	21
Prevalence of comprehensive DNA damage repair gene germline mutations in Chinese prostate cancer patients	21
Causal relationships between inflammatory factors and multiple myeloma: A bidirectional Mendelian randomization study	21
The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone‐binding globulin with risk of breast cancer among normal weight postmenopausal women in the	20
Cumulative COVID‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy	20
CD25: A potential tumor therapeutic target	20
Reviewing the impact of 11 national Be Clear on Cancer public awareness campaigns, England, 2012 to 2016: A synthesis of published evaluation results	20
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative, early‐stage breast cancer (NeoCART): Results from	20
Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases	20
Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinoma	20
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications	20
Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk	20
PARP mediated DNA damage response, genomic stability and immune responses	20
Filgrastim associations with CAR T‐cell therapy	20
Genome‐wide association study identifies an early onset pancreatic cancer risk locus	20
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma	20
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort	20
Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma	20
Risk of breast cancer and prediagnostic urinary excretion of bisphenol A, triclosan and parabens: The Multiethnic Cohort Study	20
C‐reactive protein trajectories and the risk of all cancer types: A prospective cohort study	20
Combination of Olaparib with radiotherapy for triple‐negative breast cancers: One‐year toxicity report of the RADIOPARP Phase I trial	19
Deep learning‐assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases	19
Thyroid cancer and its associated factors: A population‐based case‐control study	19
Associations of vitamin D status with colorectal cancer risk and survival	19
Annexin A2: The diversity of pathological effects in tumorigenesis and immune response	19
Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case‐control studies (SYNERGY)	19
UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β‐catenin signaling	19
Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study	19
Emerging role of oncogenic long noncoding RNA as cancer biomarkers	19
Small but strong: Mutational and functional landscapes of micronuclei in cancer genomes	19
Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome	19
High prevalence of clonal hematopoiesis‐type genomic abnormalities in cell‐free DNA in invasive gliomas after treatment	19
Acute aerobic exercise‐conditioned serum reduces colon cancer cell proliferation in vitro through interleukin‐6‐induced regulation of DNA damage	19
Comparison of liver cancer incidence and survival by subtypes across seven high‐income countries	19
A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer	19
Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants	19
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia	19
Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor‐associated myocarditis	19
Unraveling most abundant mutational signatures in head and neck cancer	19
Age‐specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub‐Saharan Africa	19
Exposures to pesticides and risk of cancer: Evaluation of recent epidemiological evidence in humans and paths forward	19
Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015	19
Fake data, paper mills, and their authors: The International Journal of Cancer reacts to this threat to scientific integrity	19
Adherence to a Western dietary pattern and risk of bladder cancer: A pooled analysis of 13 cohort studies of the Bladder Cancer Epidemiology and Nutritional Determinants international study	18
Natural history of oral HPV infection: Longitudinal analyses in prospective cohorts from Australia	18
Risk factors for immune‐related adverse events from anti‐PD‐1 or anti‐PD‐L1 treatment in an Asian cohort of nonsmall cell lung cancer patients	18
Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients	18
Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses	18
Exploiting epigenetic dependencies in ovarian cancer therapy	18
Novel mammogram‐based measures improve breast cancer risk prediction beyond an established mammographic density measure	18
Molecular and pathological basis of HPV‐negative cervical adenocarcinoma seen in a global study	18
Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma	18
Prospective study of oral microbiome and gastric cancer risk among Asian, African American and European American populations	18
Leukocyte telomere length, cancer incidence and all‐cause mortality among Chinese adults: Singapore Chinese Health Study	18
Patient‐reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy	18
Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low‐grade glioma patients—Report from the German SIOP‐LGG 2004 cohort	18
Missing and decayed teeth, oral hygiene and dental staining in relation to esophageal cancer risk: ESCCAPE case‐control study in Kilimanjaro, Tanzania	18
DNA methylation age as a biomarker for cancer	18
Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France	18
Smoking and colorectal cancer: A pooled analysis of 10 population‐based cohort studies in Japan	18
Age‐dependent performance of BRAF mutation testing in Lynch syndrome diagnostics	18
Upfront treatment with mTOR inhibitor everolimus in pediatric low‐grade gliomas: A single‐center experience	18
Population‐based human papillomavirus infection and genotype distribution among women in rural areas of South Central Ethiopia	18
Pan‐cancer analysis of prognostic metastatic phenotypes	18
KSHV dysregulates bulk macroautophagy, mitophagy and UPR to promote endothelial to mesenchymal transition and CCL2 release, key events in viral‐driven sarcomagenesis	18
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer	18
Conditional relative survival and competing mortality in patients who underwent surgery for lung cancer: A nationwide cohort study	18
Tumor promoting capacity of polymorphonuclear myeloid‐derived suppressor cells and their neutralization	17
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the Inte	17
Personalized strategies in population screening for prostate cancer	17